Sage Journals: Discover world-class research

Open access

Case report

First published 2017

Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia

Josef Finsterer, Georg Safoschnik, Martina Witsch-Baumgartner

Sage Open Medical Case Reports

Open access

Research article

First published 2021-07-30

Ancestral Origin of the First Indian Families with Myotonic Dystrophy Type 2

Manon Damen, Mascha Schijvenaars, Marlies Schimmel-Naber [...]

Journal of Neuromuscular Diseases

Retricted access

Research article

First published 1998-09

Regulation of Mouse Colony-Stimulating Factor-1 Gene Promoter Activity by AP1 and Cellular Nucleic Acid-Binding Protein

Bruce W. Konicek, Xiaoling Xia, Tripathi Rajavashisth [...]

DNA and Cell Biology

Open access

Research article

First published 2023

METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis

Shaojun Chu, Yulong Li, Baojin Wu [...]

Cell Transplantation

Free access

Research article

First published

Myotonic Dystrophy Type 2: An Update on Clinical Aspects,Genetic and Pathomolecular Mechanism

Giovanni Meola, Rosanna Cardani

Journal of Neuromuscular Diseases

Retricted access

Research article

First published 2015-12

Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2

Rea Valaperta, Fortunata Lombardi, Rosanna Cardani [...]

Genetic Testing and Molecular Biomarkers

Open access

Research article

First published 2024-11

Life expectancy and causes of death in patients with Myotonic Dystrophy Type 2

Manon J Damen, Otto G Muilwijk, Tom BG Olde Dubbelink [...]

Journal of Neuromuscular Diseases

Search results

Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia

Ancestral Origin of the First Indian Families with Myotonic Dystrophy Type 2

Regulation of Mouse Colony-Stimulating Factor-1 Gene Promoter Activity by AP1 and Cellular Nucleic Acid-Binding Protein

METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis

Myotonic Dystrophy Type 2: An Update on Clinical Aspects,Genetic and Pathomolecular Mechanism

Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2

Life expectancy and causes of death in patients with Myotonic Dystrophy Type 2